Literature DB >> 28371289

Prolonged Cold Ischemia Time Results in Local and Remote Organ Dysfunction in a Murine Model of Vascularized Composite Transplantation.

Neha Datta1, S G Devaney1, R W Busuttil1, K Azari1, J W Kupiec-Weglinski1.   

Abstract

Vascularized composite allotransplantation (VCA) is a viable reconstructive option for complex tissue defects. Although grafts with a large muscular component may be uniquely susceptible to ischemia-reperfusion (I/R) syndrome, the safe cold ischemia time in VCA has not been established. We investigated the effects of cold ischemia on innate immune response and recipient survival in a murine orthotopic hindlimb transplantation model. Surprisingly, mice receiving grafts exposed to 6 h or longer of cold storage demonstrated reduced survival and massive elevations in serum creatinine, blood urea nitrogen, and creatine kinase, compared with 1 h of cold storage recipients. This was accompanied by progressive increase in macrophage and neutrophil cell infiltration in muscle biopsy specimens, altered platelet endothelial cell adhesion molecule-1 expression, and ultimate renal injury. Multiplex immunoassay analysis identified 21 cytokines in serum and 18 cytokines in muscle biopsy specimens that are likely essential in the complex response to I/R-triggered injury in VCA. In conclusion, this study, in a mouse model of orthotopic hindlimb transplantation, is the first to document that prolonged cold ischemia triggers progressive I/R injury with vascular endothelial damage and may lead to irrecoverable local and remote organ damage. These experimental findings are important in guiding future therapies for human VCA recipients.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; immunobiology; organ perfusion and preservation; organ procurement and allocation; tissue injury and repair; vascularized composite and reconstructive transplantation

Mesh:

Substances:

Year:  2017        PMID: 28371289     DOI: 10.1111/ajt.14290

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

Review 1.  Composite tissue allotransplantation: opportunities and challenges.

Authors:  Jasper Iske; Yeqi Nian; Ryoichi Maenosono; Max Maurer; Igor M Sauer; Stefan G Tullius
Journal:  Cell Mol Immunol       Date:  2019-03-06       Impact factor: 11.530

2.  A chronic rejection model and potential biomarkers for vascularized composite allotransplantation.

Authors:  Flemming Puscz; Mehran Dadras; Alexander Dermietzel; Frank Jacobsen; Marcus Lehnhardt; Björn Behr; Tobias Hirsch; Maximilian Kueckelhaus
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

3.  Beneficial effects of the novel marine oxygen carrier M101 during cold preservation of rat and human pancreas.

Authors:  Florent Lemaire; Séverine Sigrist; Eric Delpy; Julien Cherfan; Claude Peronet; Franck Zal; Karim Bouzakri; Michel Pinget; Elisa Maillard
Journal:  J Cell Mol Med       Date:  2019-10-11       Impact factor: 5.310

4.  Successful 18-h acellular extracorporeal perfusion and replantation of porcine limbs - Histology versus nerve stimulation.

Authors:  Anne Sophie Kruit; Kaj Brouwers; Dominique van Midden; Her Zegers; Erik Koers; Nens van Alfen; Stefan Hummelink; Dietmar J O Ulrich
Journal:  Transpl Int       Date:  2021-01-05       Impact factor: 3.782

5.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 6.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

Review 7.  Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: From bench-to-bedside.

Authors:  Hirofumi Hirao; Kenneth J Dery; Shoichi Kageyama; Kojiro Nakamura; Jerzy W Kupiec-Weglinski
Journal:  Free Radic Biol Med       Date:  2020-02-19       Impact factor: 7.376

8.  Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion.

Authors:  Franka Messner; Marco Thurner; Stefan Schneeberger; Theresa Hautz; Jule Müller; Michael Blumer; Julia Hofmann; Rainer Marksteiner; Sebastien Couillard-Despres; Jakob Troppmair; Dietmar Öfner
Journal:  Stem Cell Res Ther       Date:  2021-02-24       Impact factor: 6.832

9.  Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model.

Authors:  Sarah A Hosgood; Tom Moore; Theresa Kleverlaan; Tom Adams; Michael L Nicholson
Journal:  J Transl Med       Date:  2017-10-25       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.